Harmony Biosciences Holdings, Inc.
- HRMY
- NASDAQ
- Biotechnology
- Rare Disease Pharmaceuticals (Narcolepsy)
$37.95
Today −0.84%Quote Oct 16, 2026, 08:00 PM UTC
−11.21%over the last month
Max drawdown −13.4%From 1-month high −11.2%3 months +13.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$2.21B
Quote Oct 16
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$49.00
+29.1% from here
Floor
$37.82
0.3% below price
Where the price sits
13 analysts
Analyst range, low to high
$34.00$70.00
- Price $37.95
- Resistance $37.82–$38.20
- Consensus $49.00
The price is just above its floor. Analysts' average target sits about 29% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about HRMYPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
293
Founded
2017